Biblio

Export 1008 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials., J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
Y. - Y. Huang, Chen, S. - D., Leng, X. - Y., Kuo, K., Wang, Z. - T., Cui, M., Tan, L., Wang, K., Dong, Q., and Yu, J. - T., Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management., J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
S. X. Naughton, Raval, U., and Pasinetti, G. M., Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies., J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
S. X. Naughton, Raval, U., and Pasinetti, G. M., Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies., J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial., J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
Q. Tao, Zhu, H., Chen, X., Stern, R. A., Kowall, N., Au, R., Blusztajn, J. Krzysztof, and Qiu, W. Qiao, Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications., J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
C. Lange, Suppa, P., Pietrzyk, U., Makowski, M. R., Spies, L., Peters, O., and Buchert, R., Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status., J Alzheimers Dis, vol. 61, no. 1, pp. 373-388, 2018.
L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L., Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers., J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
M. Babić Leko, Borovečki, F., Dejanović, N., Hof, P. R., and Šimić, G., Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 3, pp. 765-78, 2016.
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry., J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry., J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D., Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy., J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D., Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy., J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
B. N. Dugger, Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T., Meechoovet, B., Reiman, E. M., and Roher, A. E., The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 345-56, 2016.
H. - D. Tang, Zhou, Y., Gao, X., Liang, L., Hou, M. - M., Qiao, Y., Ma, J. - F., and Di Chen, S. -, Prevalence and Risk Factor of Cognitive Impairment were Different between Urban and Rural Population: A Community-Based Study., J Alzheimers Dis, vol. 49, no. 4, pp. 917-25, 2016.
H. - D. Tang, Zhou, Y., Gao, X., Liang, L., Hou, M. - M., Qiao, Y., Ma, J. - F., and Di Chen, S. -, Prevalence and Risk Factor of Cognitive Impairment were Different between Urban and Rural Population: A Community-Based Study., J Alzheimers Dis, vol. 49, no. 4, pp. 917-25, 2016.
D. Addesi, Maio, R., Smirne, N., Laganà, V., Altomari, N., Puccio, G., Colao, R., Cupidi, C., Perticone, F., and Bruni, A. Cecilia, Prevalence of Delirium in a Population of Elderly Outpatients with Dementia: A Retrospective Study., J Alzheimers Dis, vol. 61, no. 1, pp. 251-257, 2018.
M. R. Redston, Hilmer, S. N., McLachlan, A. J., Clough, A. J., and Gnjidic, D., Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review., J Alzheimers Dis, vol. 61, no. 4, pp. 1639-1652, 2018.
S. L. Cody, Miller, G. H., Fazeli, P. L., Wang, G., Li, W., Goodin, B. R., and Vance, D. E., Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research., J Alzheimers Dis, vol. 95, no. 3, pp. 753-768, 2023.
J. Wang, Tan, L., and Yu, J. - T., Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives., J Alzheimers Dis, vol. 50, no. 4, pp. 927-45, 2016.
A. K. Tripathi and Singh, N., Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 107-21, 2016.
A. K. Tripathi and Singh, N., Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 107-21, 2016.
M. Serpente, Fenoglio, C., Cioffi, S. Maria Giul, Oldoni, E., Arcaro, M., Arighi, A., Fumagalli, G. Giulio, Ghezzi, L., Scarpini, E., and Galimberti, D., Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients., J Alzheimers Dis, vol. 61, no. 4, pp. 1289-1294, 2018.
M. Serpente, Fenoglio, C., Cioffi, S. Maria Giul, Oldoni, E., Arcaro, M., Arighi, A., Fumagalli, G. Giulio, Ghezzi, L., Scarpini, E., and Galimberti, D., Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients., J Alzheimers Dis, vol. 61, no. 4, pp. 1289-1294, 2018.

Pages